Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Elocalcitol

Next Previous
X
Search
Drug Profile

Elocalcitol

Alternative Names: BXL 628; Vitamin D3 analogue - BioXell

Latest Information Update: 30 Dec 2011

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche
  • Developer BioXell SpA; Cosmo Pharmaceuticals
  • Class Dihydroxycholecalciferols; Small molecules; Urologics; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists; Intercellular signalling peptide and protein inhibitors; Interleukin 8 inhibitors; Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Male infertility
  • Discontinued Benign prostatic hyperplasia; Interstitial cystitis; Overactive bladder; Prostatitis

Most Recent Events

  • 12 Mar 2010 BioXell SpA has been acquired and merged into Cosmo Pharmaceuticals
  • 08 Apr 2009 Top-line efficacy data from a Phase-IIb trial in Overactive bladder released by BioXell SpA
  • 17 Dec 2008 BioXell SpA completes enrolment in its Phase-IIb trial for Overactive bladder in the EU and Ukraine

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top